- Home
- UNFI vs AUPH Comparison
UNFI vs AUPH Comparison
Compare UNFI & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNFI
- AUPH
- Stock Information
- Founded
- UNFI 1976
- AUPH 1993
- Country
- UNFI United States
- AUPH Canada
- Employees
- UNFI N/A
- AUPH N/A
- Industry
- UNFI Food Distributors
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- UNFI Consumer Discretionary
- AUPH Health Care
- Exchange
- UNFI Nasdaq
- AUPH Nasdaq
- Market Cap
- UNFI 1.2B
- AUPH 1.0B
- IPO Year
- UNFI 1996
- AUPH 1999
- Fundamental
- Price
- UNFI $21.67
- AUPH $8.12
- Analyst Decision
- UNFI Hold
- AUPH Strong Buy
- Analyst Count
- UNFI 6
- AUPH 3
- Target Price
- UNFI $17.58
- AUPH $10.33
- AVG Volume (30 Days)
- UNFI 456.0K
- AUPH 1.3M
- Earning Date
- UNFI 12-10-2024
- AUPH 11-07-2024
- Dividend Yield
- UNFI N/A
- AUPH N/A
- EPS Growth
- UNFI N/A
- AUPH N/A
- EPS
- UNFI N/A
- AUPH N/A
- Revenue
- UNFI $30,980,000,000.00
- AUPH $220,361,000.00
- Revenue This Year
- UNFI $1.15
- AUPH $36.52
- Revenue Next Year
- UNFI $0.91
- AUPH $19.02
- P/E Ratio
- UNFI N/A
- AUPH N/A
- Revenue Growth
- UNFI 2.34
- AUPH 38.72
- 52 Week Low
- UNFI $8.58
- AUPH $4.71
- 52 Week High
- UNFI $23.15
- AUPH $10.05
- Technical
- Relative Strength Index (RSI)
- UNFI 59.60
- AUPH 62.64
- Support Level
- UNFI $20.63
- AUPH $8.06
- Resistance Level
- UNFI $21.92
- AUPH $8.70
- Average True Range (ATR)
- UNFI 0.75
- AUPH 0.34
- MACD
- UNFI -0.06
- AUPH 0.07
- Stochastic Oscillator
- UNFI 80.71
- AUPH 63.74
About UNFI United Natural Foods Inc.
United Natural Foods Inc is a wholesale distributor of natural, organic and specialty foods and nonfood products across North America. The company's products consist of national, regional and private label brands grouped into grocery and general merchandise, produce, perishables and frozen foods, nutritional supplements and sports nutrition, bulk and foodservice products, and personal care items. United Natural Foods serves various retail formats including conventional supermarket chains, natural product superstores, independent retail operators and foodservice channels such as e-commerce platforms. The company's operations are comprised of principal divisions: the wholesale division; the retail division; and other.
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.